Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Socially conscious biomedical venture fund

Socially conscious biomedical venture fund

Sanderling has launched fund raising efforts for a $20 million fund, Sanderling Philanthropic & Environmental Fund L.P., designed to benefit both investors and the environment.

The fund is the brainchild of Robert McNeil, a general partner at Sanderling

Read the full 429 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers